Sign in
4

Changes in Ownership

PLIANT THERAPEUTICS, INC. Filed Acc 0001140361-23-001119

President and CEO sold 20,000 shares at an average $19.07 ($381,413)

  • President and CEO acquired 20,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Coulie Bernard · President and CEO

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2023-01-06 Exercise or conversion : show line 1 in the form +15,000 $2.08 $31,200 108,812 D
2023-01-06 Sale : show line 2 in the form −15,000 $19.04 $285,584 93,812 D
2023-01-09 Exercise or conversion : show line 3 in the form +5,000 $2.08 $10,400 98,812 D
2023-01-09 Sale : show line 4 in the form −5,000 $19.17 $95,829 93,812 D
Open-market sales · 20,000 sh · avg $19.07 · $381,413

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2023-01-06 Exercise or conversion : show line 5 in the form Stock Option (right to buy) −15,000 252,380 D
2023-01-09 Exercise or conversion : show line 6 in the form Stock Option (right to buy) −5,000 247,380 D
Loading xslF345X03/form4.xml…